Actual Medicinal Product (AMP) -
Rezzayo 200mg powder for concentrate for solution for infusion vials (Napp Pharmaceuticals Ltd)
Name Details
Current Name
Rezzayo 200mg powder for concentrate for solution for infusion vials
|
Start Date
18-01-2024
|
End Date
|
|
Abbreviated Name
Rezzayo 200mg pdr for concentrate for inf vials
|
Start Date
18-01-2024
|
|
Summary
- Licensed Route
- Intravenous
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
SNOMED Codes
Code
|
Start Date
|
End Date
|
42577211000001104 |
18-01-2024 |
|
Actual Medicinal Product Pack (AMPP) Information